Vasculopatías congénitas
Barra lateral del artículo
Contenido principal del artículo
Resumen
.
##plugins.themes.bootstrap3.displayStats.downloads##
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Blanchet AS, Cottin V, Cordier JF. Manifestations vasculaires pulmonaires de la maladie de Rendu-Osler. Presse Med. 2005;34(19 pt2):1487-95.
Cole SG, Begbie ME, Wallace GMF, et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577-82.
Fuchizaki U, Miroyamori H, Kitagawa S, et al. Hereditary haemorraghic telangiectasia (Rendu-Osler-Weber disease) . Lancet. 2003;362(9394):1490-94.
García-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HTT). J Hepatol. 2007 Mar;46(3):499-507
Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell. 2003;12(4):817-28.
Goumans M, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF-b type I receptors. EMBO J. 2002;21(7):1743-53.
Hiatjema T, Dish F, Overtoon TC, et al. Screening of family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995;99(5):519-24.
Kikuchi K, Kowada M, Sasajima H. Vascular malformations of the brain in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Surg Neurol. 1994;41(5):374-80.
Kukulj S, Ivanovi-Herceg Z, Slobodnjak Z. Hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber syndrome in the same family. Coll Antropol. 2000;24(1):241-7.
Morales Salas M, Ventura J, Ruíz Carmona E, et al. Management of epistaxis in Rendu-Osler-Weber disease. An Otorrinolaringol Ibero Am. 2001;28(3):281-91.
Pick A, Deschamps C, Stanson AW. Pulmonary arteriovenous fistula: presentation, diagnosis, and treatment. World J Surg. 1999;23(11):1118-22.
Plauchu H, de Chadarévian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32(3):291-7.
Sabba C, Pasculli G, Cirulli A, et al. Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Minerva Cardioangiol. 2002;50(3):221-38.
Shlovin CL, Guttmacher AE, Buscarani E, et al. Diagnostic criteria for hereditary hemorraghic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66-7
Sotckx L, Raat H, Caerts B, et al. Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber disease: a case report and review of the literature. Eur Radiol. 1999;9(7):1434-7
Stuhrmann M, El Harith el HA. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Saudi Med J. 2007;28(1):11-21
Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet. 2000;26(3):328-31